Viewing Study NCT00046033


Ignite Creation Date: 2025-12-25 @ 3:07 AM
Ignite Modification Date: 2025-12-26 @ 1:47 AM
Study NCT ID: NCT00046033
Status: COMPLETED
Last Update Posted: 2011-03-01
First Post: 2002-09-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module